Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression profiling defines a recurrence signature in lung squamous cell carcinoma


ABSTRACT: Lung cancer remains the leading cause of cancer death worldwide. Overall 5-year survival is about 10-15% and despite curative intent surgery, treatment failure is primarily due to recurrent disease. Conventional prognostic markers are unable to determine which patients with completely resected disease within each stage group are likely to relapse. To identify a gene signature associated with recurrent squamous cell carcinoma (SCC) of lung, we analyzed primary tumour gene expression for a total of fifty-one SCCs (stage I-III) on 22,323 element microarrays, comparing expression profiles for individuals who remained disease-free for a minimum of 36 months with those from individuals whose disease recurred within 18 months of complete resection. Cox proportional hazards modeling with leave-one-out cross-validation identified a 70-gene capable of predicting the likelihood of tumor recurrence and a 79-gene signature predictive for overall survival. These two signatures were pooled to generate a 111-gene classifier which achieved an overall predictive accuracy for disease recurrence of 72% (77% sensitivity, 67% specificity) in an independent set of fifty-eight stage I-III SCCs. This classifier also predicted differences in survival (log-rank P=0.0008, hazard ratio (HR), 3.8 [95% confidence interval, 1.6-8.7]), and was superior to conventional prognostic markers such as TNM stage or N stage in predicting patient outcome. Genome-wide profiling has revealed a distinct gene expression profile for recurrent lung SCC which may be clinically useful as a prognostic tool. Expression profiling using 22K element microarrays of 51 primary lung squamous cell carcinomas.

ORGANISM(S): Homo sapiens

SUBMITTER: Jill Larsen 

PROVIDER: E-GEOD-5123 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Expression profiling defines a recurrence signature in lung squamous cell carcinoma.

Larsen Jill Everland JE   Pavey Sandra Jane SJ   Passmore Linda Hazel LH   Bowman Rayleen R   Clarke Belinda Edith BE   Hayward Nicholas Kim NK   Fong Kwun Meng KM  

Carcinogenesis 20061101 3


Lung cancer remains the leading cause of cancer death worldwide. Overall 5-year survival is approximately 10-15% and despite curative intent surgery, treatment failure is primarily due to recurrent disease. Conventional prognostic markers are unable to determine which patients with completely resected disease within each stage group are likely to relapse. To identify a gene signature associated with recurrent squamous cell carcinoma (SCC) of lung, we analyzed primary tumor gene expression for a  ...[more]

Similar Datasets

2006-11-21 | GSE5123 | GEO
2010-05-14 | E-GEOD-14859 | biostudies-arrayexpress
2014-03-12 | E-GEOD-46837 | biostudies-arrayexpress
2010-02-09 | E-GEOD-15079 | biostudies-arrayexpress
2010-05-14 | E-GEOD-15080 | biostudies-arrayexpress
2007-05-01 | GSE5843 | GEO
2014-01-24 | E-GEOD-54352 | biostudies-arrayexpress
2014-01-24 | E-GEOD-54351 | biostudies-arrayexpress
2014-01-24 | GSE54352 | GEO
2014-01-24 | GSE54351 | GEO